Cargando…
Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention
BACKGROUND: Percutaneous coronary intervention (PCI), the preferred coronary reperfusion strategy, induces endothelial trauma which may mount an inflammatory response. This has been shown to increase the likelihood of further major adverse cardiovascular events (MACE). Colchicine, a cheap and widely...
Autores principales: | Aw, Kah Long, Koh, Amanda, Lee, Han Lin, Kudzinskas, Aurimas, De Palma, Rodney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739658/ https://www.ncbi.nlm.nih.gov/pubmed/34992158 http://dx.doi.org/10.1136/openhrt-2021-001887 |
Ejemplares similares
-
Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał A., et al.
Publicado: (2020) -
One-year outcomes of percutaneous coronary intervention in native coronary arteries versus saphenous vein grafts in patients with prior coronary artery bypass graft surgery
por: Abdelrahman, Amr, et al.
Publicado: (2022) -
The effect of bivalirudin and closure device on bleeding outcomes after percutaneous coronary interventions
por: Dobies, David R, et al.
Publicado: (2014) -
Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention
por: Vlastra, Wieneke, et al.
Publicado: (2018) -
Incidence and prognosis of late readmission after percutaneous coronary intervention
por: Freites, Alfonso, et al.
Publicado: (2023)